Article metrics

Original research
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

 

Online download statistics by month:

Online download statistics by month: October 2020 to December 2020

AbstractFullPdf
Oct 202026126176
Nov 202018118052
Dec 2020878733
Total529528161